798 / 1241
Lopez et al. Rep Pract Onc Radiot, 2015
AIM
: to analyse RT planning modification based on 11C-
Choline PET/CT in 16 prostate cancer patients
37.5% of cases: re-delineation
and new dose prescription
Data show good preliminary clinical results in terms of
biochemical control and toxicity
.